|
US8417311B2
(en)
|
2008-09-12 |
2013-04-09 |
Optiscan Biomedical Corporation |
Fluid component analysis system and method for glucose monitoring and control
|
|
WO2009049252A1
(en)
|
2007-10-10 |
2009-04-16 |
Optiscan Biomedical Corporation |
Fluid component analysis system and method for glucose monitoring and control
|
|
US7959598B2
(en)
|
2008-08-20 |
2011-06-14 |
Asante Solutions, Inc. |
Infusion pump systems and methods
|
|
US9757510B2
(en)
|
2012-06-29 |
2017-09-12 |
Animas Corporation |
Method and system to handle manual boluses or meal events for closed-loop controllers
|
|
US9486578B2
(en)
*
|
2012-12-07 |
2016-11-08 |
Animas Corporation |
Method and system for tuning a closed-loop controller for an artificial pancreas
|
|
US9907909B2
(en)
*
|
2012-12-20 |
2018-03-06 |
Animas Corporation |
Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
|
|
KR102212020B1
(ko)
*
|
2013-01-14 |
2021-02-05 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
제1형 당뇨병 응용을 위한 인공 췌장에 대한 모델 예측 제어 문제에서의 일주기 목표-구역 조절
|
|
EP2973095B1
(en)
|
2013-03-15 |
2018-05-09 |
Animas Corporation |
Insulin time-action model
|
|
US9795737B2
(en)
|
2013-03-15 |
2017-10-24 |
Animas Corporation |
Method and system for closed-loop control of an artificial pancreas
|
|
US9517306B2
(en)
|
2013-03-15 |
2016-12-13 |
Animas Corporation |
Method and system for closed-loop control of an artificial pancreas
|
|
US9561324B2
(en)
|
2013-07-19 |
2017-02-07 |
Bigfoot Biomedical, Inc. |
Infusion pump system and method
|
|
US9474855B2
(en)
|
2013-10-04 |
2016-10-25 |
Animas Corporation |
Method and system for controlling a tuning factor due to sensor replacement for closed-loop controller in an artificial pancreas
|
|
US9861747B2
(en)
|
2013-12-05 |
2018-01-09 |
Lifescan, Inc. |
Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing
|
|
GB2523989B
(en)
|
2014-01-30 |
2020-07-29 |
Insulet Netherlands B V |
Therapeutic product delivery system and method of pairing
|
|
AU2015301146B2
(en)
|
2014-08-06 |
2020-06-25 |
Regents Of The University Of California |
Moving-horizon state-initializer for control applications
|
|
CN111905188B
(zh)
|
2015-02-18 |
2022-07-22 |
英赛罗公司 |
流体输送和输注装置及其使用方法
|
|
US10275573B2
(en)
|
2016-01-13 |
2019-04-30 |
Bigfoot Biomedical, Inc. |
User interface for diabetes management system
|
|
US10806859B2
(en)
|
2016-01-14 |
2020-10-20 |
Bigfoot Biomedical, Inc. |
Adjusting insulin delivery rates
|
|
HK1256995A1
(zh)
|
2016-01-14 |
2019-10-11 |
Bigfoot Biomedical, Inc. |
药物输送设备、系统和方法中的阻塞解决方案
|
|
FR3047098B1
(fr)
*
|
2016-01-21 |
2018-05-25 |
Voluntis |
Gestion de l'equilibre glycemique d'un patient diabetique
|
|
RU2737326C2
(ru)
*
|
2016-02-05 |
2020-11-27 |
Энимас Корпорейшн |
Средство наглядного представления и анализа для системы доставки лекарственных средств
|
|
US12383166B2
(en)
|
2016-05-23 |
2025-08-12 |
Insulet Corporation |
Insulin delivery system and methods with risk-based set points
|
|
WO2018058041A1
(en)
|
2016-09-23 |
2018-03-29 |
Insulet Corporation |
Fluid delivery device with sensor
|
|
CA3037432A1
(en)
|
2016-12-12 |
2018-06-21 |
Bigfoot Biomedical, Inc. |
Alarms and alerts for medication delivery devices and related systems and methods
|
|
US10583250B2
(en)
|
2017-01-13 |
2020-03-10 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US10758675B2
(en)
|
2017-01-13 |
2020-09-01 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
US10881793B2
(en)
|
2017-01-13 |
2021-01-05 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
EP3568860B1
(en)
|
2017-01-13 |
2025-12-10 |
Insulet Corporation |
Insulin delivery methods, systems and devices
|
|
US10500334B2
(en)
|
2017-01-13 |
2019-12-10 |
Bigfoot Biomedical, Inc. |
System and method for adjusting insulin delivery
|
|
EP4708311A2
(en)
|
2017-01-13 |
2026-03-11 |
Insulet Corporation |
Insulin delivery methods, systems and devices
|
|
US11497851B2
(en)
|
2017-03-31 |
2022-11-15 |
Lifescan Ip Holdings, Llc |
Maintaining maximum dosing limits for closed loop insulin management systems
|
|
US10729849B2
(en)
|
2017-04-07 |
2020-08-04 |
LifeSpan IP Holdings, LLC |
Insulin-on-board accounting in an artificial pancreas system
|
|
US11147920B2
(en)
|
2017-04-18 |
2021-10-19 |
Lifescan Ip Holdings, Llc |
Diabetes management system with automatic basal and manual bolus insulin control
|
|
CA3198598A1
(en)
|
2017-05-05 |
2018-11-08 |
Eli Lilly And Company |
Closed loop control of physiological glucose
|
|
EP3438858A1
(en)
|
2017-08-02 |
2019-02-06 |
Diabeloop |
Closed-loop blood glucose control systems and methods
|
|
WO2019125932A1
(en)
|
2017-12-21 |
2019-06-27 |
Eli Lilly And Company |
Closed loop control of physiological glucose
|
|
JP6938363B2
(ja)
*
|
2017-12-27 |
2021-09-22 |
オムロンヘルスケア株式会社 |
情報処理装置、生体情報測定装置、方法及びプログラム
|
|
USD928199S1
(en)
|
2018-04-02 |
2021-08-17 |
Bigfoot Biomedical, Inc. |
Medication delivery device with icons
|
|
US11147919B2
(en)
|
2018-04-23 |
2021-10-19 |
Medtronic Minimed, Inc. |
Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system
|
|
US11158413B2
(en)
*
|
2018-04-23 |
2021-10-26 |
Medtronic Minimed, Inc. |
Personalized closed loop medication delivery system that utilizes a digital twin of the patient
|
|
EP3788628B1
(en)
|
2018-05-04 |
2024-12-11 |
Insulet Corporation |
Safety constraints for a control algorithm-based drug delivery system
|
|
US12562251B1
(en)
|
2018-05-09 |
2026-02-24 |
Bigfoot Biomedical, Inc. |
Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
|
|
CN112313754A
(zh)
|
2018-06-22 |
2021-02-02 |
伊莱利利公司 |
胰岛素和普兰林肽输送系统、方法和设备
|
|
US11628251B2
(en)
|
2018-09-28 |
2023-04-18 |
Insulet Corporation |
Activity mode for artificial pancreas system
|
|
EP3864668A1
(en)
|
2018-10-11 |
2021-08-18 |
Insulet Corporation |
Event detection for drug delivery system
|
|
USD920343S1
(en)
|
2019-01-09 |
2021-05-25 |
Bigfoot Biomedical, Inc. |
Display screen or portion thereof with graphical user interface associated with insulin delivery
|
|
US11986629B2
(en)
|
2019-06-11 |
2024-05-21 |
Medtronic Minimed, Inc. |
Personalized closed loop optimization systems and methods
|
|
US11801344B2
(en)
|
2019-09-13 |
2023-10-31 |
Insulet Corporation |
Blood glucose rate of change modulation of meal and correction insulin bolus quantity
|
|
US11935637B2
(en)
|
2019-09-27 |
2024-03-19 |
Insulet Corporation |
Onboarding and total daily insulin adaptivity
|
|
WO2021113647A1
(en)
|
2019-12-06 |
2021-06-10 |
Insulet Corporation |
Techniques and devices providing adaptivity and personalization in diabetes treatment
|
|
US11833329B2
(en)
|
2019-12-20 |
2023-12-05 |
Insulet Corporation |
Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
|
|
JP7512395B2
(ja)
|
2020-01-06 |
2024-07-08 |
インスレット コーポレイション |
持続する残差に基づく食事および／または運動行為の予測
|
|
US12370307B2
(en)
|
2020-02-03 |
2025-07-29 |
Insulet Corporation |
Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device
|
|
US11551802B2
(en)
|
2020-02-11 |
2023-01-10 |
Insulet Corporation |
Early meal detection and calorie intake detection
|
|
US11547800B2
(en)
|
2020-02-12 |
2023-01-10 |
Insulet Corporation |
User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
|
|
US11986630B2
(en)
|
2020-02-12 |
2024-05-21 |
Insulet Corporation |
Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
|
|
US11324889B2
(en)
|
2020-02-14 |
2022-05-10 |
Insulet Corporation |
Compensation for missing readings from a glucose monitor in an automated insulin delivery system
|
|
US12495994B2
(en)
|
2020-02-20 |
2025-12-16 |
Insulet Corporation |
Meal bolus subcategories in model based insulin therapy
|
|
US11607493B2
(en)
|
2020-04-06 |
2023-03-21 |
Insulet Corporation |
Initial total daily insulin setting for user onboarding
|
|
WO2022020197A1
(en)
|
2020-07-22 |
2022-01-27 |
Insulet Corporation |
Open-loop insulin delivery basal parameters based on insulin delivery records
|
|
US11684716B2
(en)
|
2020-07-31 |
2023-06-27 |
Insulet Corporation |
Techniques to reduce risk of occlusions in drug delivery systems
|
|
US12569619B2
(en)
|
2020-09-21 |
2026-03-10 |
Insulet Corporation |
Techniques for determining automated insulin delivery dosages
|
|
EP4221588A1
(en)
|
2020-09-30 |
2023-08-09 |
Insulet Corporation |
Secure wireless communications between a glucose monitor and other devices
|
|
WO2022072332A1
(en)
|
2020-09-30 |
2022-04-07 |
Insulet Corporation |
Drug delivery device with integrated optical-based glucose monitor
|
|
US11160925B1
(en)
|
2021-01-29 |
2021-11-02 |
Insulet Corporation |
Automatic drug delivery system for delivery of a GLP-1 therapeutic
|
|
US11904140B2
(en)
|
2021-03-10 |
2024-02-20 |
Insulet Corporation |
Adaptable asymmetric medicament cost component in a control system for medicament delivery
|
|
EP4305636A1
(en)
|
2021-03-10 |
2024-01-17 |
Insulet Corporation |
A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
|
|
US12592306B2
(en)
|
2021-04-28 |
2026-03-31 |
Insulet Corporation |
Devices and methods for initialization of drug delivery devices using measured analyte sensor information
|
|
US12496398B2
(en)
|
2021-05-28 |
2025-12-16 |
Insulet Corporation |
Threshold based automatic glucose control response
|
|
US12406760B2
(en)
|
2021-06-07 |
2025-09-02 |
Insulet Corporation |
Exercise safety prediction based on physiological conditions
|
|
US12514980B2
(en)
|
2021-06-30 |
2026-01-06 |
Insulet Corporation |
Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
|
|
US12521486B2
(en)
|
2021-07-16 |
2026-01-13 |
Insulet Corporation |
Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
|
|
WO2023049900A1
(en)
|
2021-09-27 |
2023-03-30 |
Insulet Corporation |
Techniques enabling adaptation of parameters in aid systems by user input
|
|
US11439754B1
(en)
|
2021-12-01 |
2022-09-13 |
Insulet Corporation |
Optimizing embedded formulations for drug delivery
|
|
EP4243030A1
(en)
|
2022-03-09 |
2023-09-13 |
Insulet Corporation |
Adjusting medicament delivery parameters in an open loop medicament delivery mode
|
|
CN120457493A
(zh)
|
2023-01-06 |
2025-08-08 |
英赛罗公司 |
自动或手动启动的随餐推注输送及随后的自动安全约束放宽
|
|
US20250166810A1
(en)
*
|
2023-11-22 |
2025-05-22 |
Cilag Gmbh International |
Data streams multi-system interaction
|